130 results
8-K
EX-3.1
BMY
Bristol-Myers Squibb Co.
19 Sep 14
Amendments to Articles of Incorporation or Bylaws
12:00am
of Stockholders — No Action by Written Consent; Calling of Special Meeting
Meetings of Stockholders — Notice
Meetings of Stockholders — Quorum
Meetings … such public announcement is first made by the Company.
(b) Only such business shall be conducted at a special meeting of stockholders as shall have been
PRRN14A
BMY
Bristol-Myers Squibb Co.
13 Mar 19
Revised preliminary proxy statement filed by non-management
12:00am
-Myers (the “Merger”) at the special meeting of stockholders of Bristol-Myers to be held on April 12, 2019 (including any adjournments or postponements … thereof, the “Special Meeting”).
Pursuant to the terms of the merger agreement entered into by Bristol-Myers and Celgene on January 2, 2019
8-K
EX-3
BMY
Bristol-Myers Squibb Co.
4 May 21
Departure of Directors or Certain Officers
4:16pm
Meetings of Stockholders – No Action by Written Consent; Calling of Special Meeting
Meetings of Stockholders – Notice
Meetings of Stockholders – Quorum … on which such public announcement is first made by the Company.
Only such business shall be conducted at a special meeting of stockholders as shall
S-4
EX-99.1
4l3zyvwliqmdtiu
2 Aug 96
Registration of securities issued in business combination transactions
12:00am
DEFC14A
71z6eon
15 Mar 19
Proxy in contested solicitation
12:31pm
DFAN14A
cq81 6jeeq8ksa7
29 Mar 19
Additional proxy materials by non-management
3:58pm
PREC14A
so5tj3 vqb
1 Mar 19
Preliminary proxy with contested solicitation
4:59pm
8-K
EX-3
l2kcph 96j16imanlfz
10 May 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
zpf 7ichfey0
12 May 14
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
obxn38d
11 Dec 13
Departure of Directors or Certain Officers
12:00am
424B3
1akze8
22 Feb 19
Prospectus supplement
4:31pm
DFAN14A
5cjd9j8v2u0k
19 Mar 19
Additional proxy materials by non-management
4:56pm
DFAN14A
jgdyefgd4w zwc94zujg
6 Mar 19
Additional proxy materials by non-management
5:15pm
425
u3ubwttp2 vd5
12 Apr 19
Business combination disclosure
5:25pm
DFAN14A
p5t81ynk6enp
28 Feb 19
Additional proxy materials by non-management
5:06pm
8-K
lubzi612m87s0e sobi
12 Apr 19
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
5:27pm